WOCKPHARMA Wockhardt Ltd Product Launches Announcement 2024 - New Drug Success Wockhardts investigational drug Zaynich™ (Zidebactam/Cefepime) has successfully treated over 35 critically ill patients suffering from extremely drug-resistant infections, including a complex case of meningitis caused by a pan-drug resistant super-bug, showcasing its effectiveness and good tolerability..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Wockhardt Ltd